Showing 2371-2380 of 4166 results for "".
- Johnson & Johnson Vision’s Acuvue Abiliti Brand Launches Back-to-School Campaign to Address Myopiahttps://modernod.com/news/johnson-johnson-visions-acuvue-abiliti-brand-launches-back-to-school-campaign-to-address-myopia/2481762/Johnson & Johnson Vision, part of Johnson & Johnson MedTech, announced that its Acuvue Abiliti brand is initiating a Back-to-School campaign to inform parents about the growing risk of myopia and encourage them to schedule a comprehensive eye exam for their children ahead of the new schoo
- Elios Vision Completes Enrollment in US Pivotal Trial; Expands US Pre-Launch Teamhttps://modernod.com/news/elios-vision-completes-enrollment-in-us-pivotal-trial-expands-us-pre-launch-team-and-continues-to-generate-commercial-uptake-in-europe/2481701/Elios Vision announced it has completed enrollment for its pivotal trial of more than 300 patients with mild to moderate glaucoma treated with the Elios procedure in combination with cataract surgery. Elios is an implant-free procedure that uses excimer laser technology for the treatmen
- Bausch + Lomb Announces New Scientific Data and Analyses Featuring Consumer, Vision Care and Pharmaceuticals Will Be Presented During Optometry's Meetinghttps://modernod.com/news/bausch-lomb-announces-new-scientific-data-and-analyses-featuring-consumer-vision-care-and-pharmaceuticals-will-be-presented-during-optometrys-meeting/2481662/Bausch + Lomb announced that researchers will present the results of 11 scientific poster presentations involving the company’s consumer, vision care and pharmaceutical products during the American Optometric Association (AOA) Optometry’s Meeting e-posters virtual event, which is taki
- Apple Provides New Vision Health Features on iOS 17, iPadOS 17, and WatchOS 10https://modernod.com/news/apples-provides-new-vision-health-features-on-ios-17-ipados-17-and-watchos-10/2481655/Apple announced new health features in iOS 17, iPadOS 17, and watchOS 10, expanding into mental health and vision health and providing innovative tools and experiences across platforms. New mental health features allow users to log their momentary emotions and daily moods
- Delta Gamma Foundation Awards RestoringVision with Grant to Serve People in Need of Vision Services and Eyeglasses in the UShttps://modernod.com/news/delta-gamma-foundation-awards-restoringvision-with-grant-to-serve-people-in-need-of-vision-services-and-eyeglasses-in-the-us/2481609/RestoringVision, a global nonprofit, recently won its third Service for Sight grant from the Delta Gamma Foundation. The funding will support bringing vision services and eyeglasses to 270,000 low-income people in the United States, according to RestoringVision. The award supports
- Johnson & Johnson Vision to Present and Support 43 Company-Sponsored and Investigator-Led Studies at ASCRShttps://modernod.com/news/johnson-johnson-vision-to-present-and-support-43-company-sponsored-and-investigator-led-studies-at-ascrs/2481593/Johnson & Johnson Vision will present and support 43 company-sponsored and investigator-led studies evaluating innovation, outcomes and satisfaction rates across its surgical portfolio at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in San Diego, May 5-8
- Johnson & Johnson Vision Receives FDA Clearance for its Elita Femtosecond Laserhttps://modernod.com/news/johnson-johnson-vision-receives-fda-clearance-for-its-elita-femtosecond-laser/2481573/Johnson & Johnson Vision announced that it has received FDA 510(k) clearance for the Elita Femtosecond Laser for the creation of LASIK flaps. Elita will be unveiled at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) in San Diego, May 5-8
- Iveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trialshttps://modernod.com/news/iveric-bio-announces-new-functional-vision-loss-reduction-data-from-avacincaptad-pegol-gather-trials/2481557/Iveric bio announced new findings from exploratory analyses of data for avacincaptad pegol (ACP), which were presented at the 2023 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) in New Orleans. A post-hoc analysis from the GATHER1 and GATHER2
- SightGlass Vision: Research Reinforces Myopia Control Efficacy and Safety of Diffusion Optics Technology Spectacle Lenseshttps://modernod.com/news/sightglass-vision-research-reinforces-myopia-control-efficacy-and-safety-of-diffusion-optics-technology-spectacle-lenses/2481552/SightGlass Vision announced positive outcomes of multiple studies designed to evaluate the performance of its Diffusion Optics Technology spectacle lenses, which are designed to slow the progression of myopia in children. All are being presented this week at the 2023 ARVO Annual Me
- International Sports Vision Association Announces Leadership Appointments OF NEW EXECUTIVE AND ADVISORY BOARD OFFICERShttps://modernod.com/news/international-sports-vision-association-announces-leadership-appointments-of-new-executive-and-advisory-board-officers/2481491/The International Sports Vision Association (ISVA) announced the appointments of its new Executive and Advisory Board members, effective April 1, 2023. Executive Board Alireza Somji, OD assumes the position of President, succeeding Charles Shidlofsky, OD, FCOV